Research ArticleSKIN DISEASE

Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa

See allHide authors and affiliations

Science Translational Medicine  26 Nov 2014:
Vol. 6, Issue 264, pp. 264ra165
DOI: 10.1126/scitranslmed.3010083

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article